Antagonist angiotenzin II receptora (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "Antagonist angiotenzin II receptora" in Serbian language version.
refsWebsite
Global rank
Serbian rank
6th place
5th place
1st place
1st place
low place
low place
archive.org
- Gales BJ, Bailey EK, Reed AN, Gales MA (2010). „Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines”. Ann Pharmacother. 44 (2): 360—6. PMID 20086184. doi:10.1345/aph.1M312.
bentham-direct.org
- Daskalopoulou SS, Tzovaras V, Mikhailidis DP, Elisaf M (2005). „Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia”. Curr. Pharm. Des. 11 (32): 4161—75. PMID 16375738. doi:10.2174/138161205774913309. Архивирано из оригинала 24. 05. 2009. г. Приступљено 07. 10. 2018.
doi.org
- Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G (2003). „Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial”. JAMA. 1 (289 Pt 1): 65—9. PMID 12503978. doi:10.1001/jama.289.1.65.
- Cernes R, Mashavi M, Zimlichman R (2011). „Differential clinical profile of candesartan compared to other angiotensin receptor blockers”. Vasc Health Risk Manag. 7: 749—59. PMC 3253768
. PMID 22241949. doi:10.2147/VHRM.S22591. - Gales BJ, Bailey EK, Reed AN, Gales MA (2010). „Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines”. Ann Pharmacother. 44 (2): 360—6. PMID 20086184. doi:10.1345/aph.1M312.
- Kassler-Taub K, Littlejohn T, Elliott W, Ruddy T, Adler E (1998). „Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators”. Am J Hypertens. 11 (4 Pt 1): 445—53. PMID 9607383. doi:10.1016/S0895-7061(97)00491-3.
- Dang A, Zhang Y, Liu G, Chen G, Song W, Wang B (2006). „Effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia in Chinese population”. J Hum Hypertens. 20 (1): 45—50. PMID 16281062. doi:10.1038/sj.jhh.1001941.
- Daskalopoulou SS, Tzovaras V, Mikhailidis DP, Elisaf M (2005). „Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia”. Curr. Pharm. Des. 11 (32): 4161—75. PMID 16375738. doi:10.2174/138161205774913309. Архивирано из оригинала 24. 05. 2009. г. Приступљено 07. 10. 2018.
nih.gov
ncbi.nlm.nih.gov
- Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G (2003). „Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial”. JAMA. 1 (289 Pt 1): 65—9. PMID 12503978. doi:10.1001/jama.289.1.65.
- Cernes R, Mashavi M, Zimlichman R (2011). „Differential clinical profile of candesartan compared to other angiotensin receptor blockers”. Vasc Health Risk Manag. 7: 749—59. PMC 3253768 . PMID 22241949. doi:10.2147/VHRM.S22591.
- Gales BJ, Bailey EK, Reed AN, Gales MA (2010). „Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines”. Ann Pharmacother. 44 (2): 360—6. PMID 20086184. doi:10.1345/aph.1M312.
- Kassler-Taub K, Littlejohn T, Elliott W, Ruddy T, Adler E (1998). „Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators”. Am J Hypertens. 11 (4 Pt 1): 445—53. PMID 9607383. doi:10.1016/S0895-7061(97)00491-3.
- Dang A, Zhang Y, Liu G, Chen G, Song W, Wang B (2006). „Effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia in Chinese population”. J Hum Hypertens. 20 (1): 45—50. PMID 16281062. doi:10.1038/sj.jhh.1001941.
- Daskalopoulou SS, Tzovaras V, Mikhailidis DP, Elisaf M (2005). „Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia”. Curr. Pharm. Des. 11 (32): 4161—75. PMID 16375738. doi:10.2174/138161205774913309. Архивирано из оригинала 24. 05. 2009. г. Приступљено 07. 10. 2018.
web.archive.org
- Daskalopoulou SS, Tzovaras V, Mikhailidis DP, Elisaf M (2005). „Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia”. Curr. Pharm. Des. 11 (32): 4161—75. PMID 16375738. doi:10.2174/138161205774913309. Архивирано из оригинала 24. 05. 2009. г. Приступљено 07. 10. 2018.